SafeStart - An intervention study to promote safe medication use in pregnancy
The SafeStart study is a randomized controlled study among 15 community pharmacies in Norway. All Norwegian speaking pregnant women over the age of 18 are eligible for inclusion. Read more on the official Norwegian SafeStart web-page.
The objective of this study is to investigate whether a pharmacist's intervention in early pregnancy can optimize pregnant women's management of pregnancy-related ailments and improve their quality of life.
Pregnant women tend to overestimate the teratogenic risk of medications - often resulting in unfound anxiety and non-adherence to needed medication. Pharmacist interventions have shown to improve medication use and outcomes in other patient populations, but no studies have investigated the effects of a pharmacist intervention as part of antenatal care.
The project is funded by the University of Oslo, ExtraStiftelsen via Norwegian Women's Public Health Association, the Foundation for Promotion of Norwegian Pharmacies, The Norwegian PhD School of Pharmacy and the Norwegian Pharmaceutical Society.
The Norwegian Pharmacy Association, the Norwegian patient organization for Hyperemesis Gravidarum (HG), University of Alberta, Canada and University of Massachusettes, USA. The Regional Drug Information Centre (RELIS Sør-Øst) and clinical pharmacists from Oslo University Hospital and Diakonhjemme Hospital are also involved.